Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of LY2148568 in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s) But Not Well Controlled

NCT00577824 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00577824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00577824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of LY2148568 in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s) But Not Well Controlled
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2008
Completion date
November 30, 2008
Enrollment
181 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes